WebApr 10, 2024 · On April 10, the Japanese pharma giant announced it received the FDA designation for TP-1287 in the rare bone cancer Ewing sarcoma. Sumitomo is currently developing TP-1287 in a Phase I trial targeting advanced solid tumors (NCT03604783) through its Cambridge, Massachusetts-based subsidiary Sumitomo Pharma Oncology. WebFirst, Japan has taken a number of steps to make it easier to include the country in global trials. Second, Japan is encouraging its own drug companies to reach out to …
How To Run Successful Clinical Trials In Japan - CMIC Group
WebApr 12, 2024 · TOKYO, April 12, 2024—Canon Inc. announced today that the company Canon Inc., Canon Medical Systems Corporation (Canon Medical), and the National Cancer Center Japan (NCC) have begun clinical research employing a next-generation X-ray CT system with photon counting computed tomography (photon-counting CT, PCCT). … WebDec 13, 2024 · The Clinical Trials Act encourages investigators and industries to follow appropriate processes and procedures, and to be transparent in the conduct and reporting of their studies by imposing penalties for violation of the law. ind vs sl time table
The Current Status and Future Direction of Clinical Research in …
WebClinical research in Japan: past, present and future Clinical research in Japan: past, present and future Authors Yuji Sato 1 , Keisuke Koyama Affiliation 1 Centre for Clinical … WebJCOG9110. I. Phase I Clinical Trial of Irinotecan (CPT-11), 7-Ethyl-10- [4- (1-piperidino)-1-piperidino] carbonyloxy-camptothecin, and Cisplatin in Combination with Fixed Dose of … WebApr 10, 2024 · The National Cancer Center (President: Hitoshi Nakagama, Chuo-ku, Tokyo) Hospital (Director: Kazuaki Shimada) has conducted a phase II investigator-initiated STATICE trial at seven facilities in Japan to evaluate the efficacy of the anti-HER2 antibody-drug conjugate trastuzumab deruxtecan in patients with uterine carcinosarcoma … ind vs sl wc 2011